celecoxib has been researched along with Neuralgia in 15 studies
Neuralgia: Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neuropathic pain affects millions of people worldwide, yet the molecular mechanisms of how it develops and persists are poorly understood." | 1.72 | Behavioral and inflammatory sex differences revealed by celecoxib nanotherapeutic treatment of peripheral neuroinflammation. ( Deal, B; Janjic, JM; Patterson, C; Pollock, JA; Reynolds, LM, 2022) |
| "Left sciatic nerve ligation was used as neuropathic pain model." | 1.48 | Efficacy and safety of combined low doses of either diclofenac or celecoxib with gabapentin versus their single high dose in treatment of neuropathic pain in rats. ( Abdelwahab, S; Abdelzaher, WY; Ibrahim, MA; Rofaeil, RR, 2018) |
| "In a mice model of neuropathic pain induced by oxaliplatin, one of the strong CA II/VII inhibitors reported here induced a long lasting pain relieving effect, a fact never observed earlier." | 1.42 | A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects. ( Carta, F; Di Cesare Mannelli, L; Ghelardini, C; McKenna, R; Pinard, M; Scozzafava, A; Supuran, CT, 2015) |
| "In a diabetic neuropathic pain model, pretreatment with celecoxib, L-NIL and 7-Ni, significantly increased the antihyperalgesic activity of both Met-F-AEA and AM 1241." | 1.42 | Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy. ( Bujalska-Zadrożny, M; de Cordé, A; Pawlik, K, 2015) |
| "Celecoxib (CXB) is a widely prescribed COX-2 inhibitor used clinically to treat pain and inflammation." | 1.39 | The role of potassium channel activation in celecoxib-induced analgesic action. ( Du, X; Gao, H; Huang, D; Li, L; Mi, Y; Qi, J; Zhang, F; Zhang, H; Zhang, X, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 11 (73.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Carta, F | 1 |
| Di Cesare Mannelli, L | 1 |
| Pinard, M | 1 |
| Ghelardini, C | 1 |
| Scozzafava, A | 1 |
| McKenna, R | 1 |
| Supuran, CT | 1 |
| Deal, B | 2 |
| Reynolds, LM | 1 |
| Patterson, C | 1 |
| Janjic, JM | 2 |
| Pollock, JA | 2 |
| Abd-Elmawla, MA | 1 |
| Abdelalim, E | 1 |
| Ahmed, KA | 1 |
| Rizk, SM | 1 |
| Ibrahim, MA | 1 |
| Abdelzaher, WY | 1 |
| Rofaeil, RR | 1 |
| Abdelwahab, S | 1 |
| Li, Z | 1 |
| Zeng, J | 1 |
| Nie, H | 1 |
| Jiang, H | 1 |
| Xie, T | 1 |
| Song, Y | 1 |
| Saleem, M | 1 |
| Nehl, E | 1 |
| Lee, JY | 2 |
| Choi, HY | 1 |
| Park, CS | 1 |
| Jang, C | 1 |
| Lee, KT | 1 |
| Youn, I | 1 |
| Yune, TY | 1 |
| Bujalska-Zadrożny, M | 1 |
| de Cordé, A | 1 |
| Pawlik, K | 1 |
| Qureshi, RA | 1 |
| Tian, Y | 1 |
| McDonald, MK | 1 |
| Capasso, KE | 1 |
| Douglas, SR | 1 |
| Gao, R | 1 |
| Orlova, IA | 1 |
| Barrett, JE | 1 |
| Ajit, SK | 1 |
| Sacan, A | 1 |
| Moore, RA | 1 |
| Chi, CC | 1 |
| Wiffen, PJ | 1 |
| Derry, S | 1 |
| Rice, AS | 1 |
| Jiang, SP | 1 |
| Zhang, ZD | 1 |
| Kang, LM | 1 |
| Wang, QH | 1 |
| Zhang, L | 1 |
| Chen, HP | 1 |
| Lau, WK | 1 |
| Lau, YM | 1 |
| Zhang, HQ | 1 |
| Wong, SC | 1 |
| Bian, ZX | 1 |
| Mi, Y | 1 |
| Zhang, X | 1 |
| Zhang, F | 1 |
| Qi, J | 1 |
| Gao, H | 1 |
| Huang, D | 1 |
| Li, L | 1 |
| Zhang, H | 1 |
| Du, X | 1 |
| Rodrigues-Filho, R | 1 |
| Campos, MM | 1 |
| Ferreira, J | 1 |
| Santos, AR | 1 |
| Bertelli, JA | 1 |
| Calixto, JB | 1 |
| Reuben, SS | 1 |
1 review available for celecoxib and Neuralgia
| Article | Year |
|---|---|
Oral nonsteroidal anti-inflammatory drugs for neuropathic pain.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Back Pain; Celecoxib; Humans; | 2015 |
14 other studies available for celecoxib and Neuralgia
| Article | Year |
|---|---|
A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects.
Topics: Analgesics; Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Crystallography, X-Ray; Hum | 2015 |
Behavioral and inflammatory sex differences revealed by celecoxib nanotherapeutic treatment of peripheral neuroinflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Female; Humans; Male; | 2022 |
The neuroprotective effect of pterostilbene on oxaliplatin-induced peripheral neuropathy via its anti-inflammatory, anti-oxidative and anti-apoptotic effects: Comparative study with celecoxib.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Celecoxib; Cyclooxygenase 2; Cytokines; Neuralgia; | 2023 |
Efficacy and safety of combined low doses of either diclofenac or celecoxib with gabapentin versus their single high dose in treatment of neuropathic pain in rats.
Topics: Amines; Analgesics; Animals; Behavior, Animal; Celecoxib; Cyclohexanecarboxylic Acids; Diclofenac; D | 2018 |
[Effectiveness of combined Pregabalin and Celecoxib for treatment of neuropathic pain after percutaneous endoscopic lumbar discectomy].
Topics: Analgesics; Celecoxib; Diskectomy, Percutaneous; Humans; Intervertebral Disc Displacement; Lumbar Ve | 2017 |
Nanomedicine-driven neuropathic pain relief in a rat model is associated with macrophage polarity and mast cell activation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cell Polarity; Disease Models, Animal; | 2019 |
Inhibition of COX-2 alleviates lumbar spinal stenosis-induced chronic mechanical allodynia in rats.
Topics: Animals; Cauda Equina; Celecoxib; Chronic Pain; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytok | 2019 |
Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy.
Topics: Animals; Arachidonic Acids; Cannabinoids; Celecoxib; Cyclooxygenase Inhibitors; Diabetic Neuropathie | 2015 |
Circulating microRNA Signatures in Rodent Models of Pain.
Topics: Animals; Celecoxib; Circulating MicroRNA; Disease Models, Animal; Freund's Adjuvant; Gene Expression | 2016 |
Celecoxib reverts oxaliplatin-induced neuropathic pain through inhibiting PI3K/Akt2 pathway in the mouse dorsal root ganglion.
Topics: Animals; Apoptosis; Celecoxib; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2 Inhibitors; Ganglia | 2016 |
Electroacupuncture versus celecoxib for neuropathic pain in rat SNL model.
Topics: Acupuncture Points; Analgesics; Animals; Celecoxib; Cyclooxygenase 2; Disease Models, Animal; Electr | 2010 |
The role of potassium channel activation in celecoxib-induced analgesic action.
Topics: Analgesics; Celecoxib; Ganglia, Spinal; HEK293 Cells; Humans; Neuralgia; Neurons; Pain Management; P | 2013 |
Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain.
Topics: Acetates; Amines; Analgesics; Analysis of Variance; Animals; Brachial Plexus; Brachial Plexus Neurop | 2004 |
The prevention of post-surgical neuralgia.
Topics: Analgesics; Celecoxib; Cyclohexanols; Cyclooxygenase Inhibitors; Double-Blind Method; Humans; Incide | 2005 |